COLLEGIUM PHARMACEUTICAL, INC (COLL)
Pharmaceutical Preparations
Latest Price
$35.39
TTM P/E
17.18
Normalized P/E
40.02
Div Yield
--
Book Value
9.74
P/B Ratio
3.63
Valuation metrics
adjust assumptions →EPS: $1.73
Book value / share: $9.51
Formula: √(22.5 × EPS × BVPS)
Graham Number
$19.24
46% downside
Norm. op. income: $56M (median of 7yr)
Tax rate: 31%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$24.08
32% downside
Base FCF: $203M (median of recent 5yr)
Growth: 23%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$419.86
+1086% upside
EPS: $1.73
Target P/E: 40×
Formula: EPS × P/E
P/E Fair Value
$69.20
+96% upside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.13M | $169.0M | 15.84% | +34.3K | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 1.83M | $60.0M | 5.63% | +377.1K | 2026-03-31 |
| Invesco Ltd. | 1.59M | $52.0M | 4.91% | +416.9K | 2026-03-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.50M | $49.0M | 4.63% | -488 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1.47M | $48.0M | 4.53% | -147.9K | 2026-03-31 |
| STATE STREET CORP | 1.42M | $47.0M | 4.40% | +113.9K | 2026-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.42M | $47.0M | 4.39% | -452.0K | 2026-03-31 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.37M | $45.0M | 4.21% | +53.3K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.33M | $44.0M | 4.12% | -- | 2026-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 1.30M | $42.0M | 4.00% | -18.6K | 2026-03-31 |